Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 5/20 | 0.67 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.46 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.46 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ACACB | O00763 | 1/20 | 0.39 |
| ▸ | ACACA | Q13085 | 1/20 | 0.39 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.39 |
| ▸ | CAMK2A | Q9UQM7 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6032892 | 1.00 | GPR84 (0.67) | GPR84SLC22A6PTPN1FFAR1FFAR4 | |
| SCHEMBL18585525 | 1.00 | GPR84 (0.67) | GPR84SLC22A6PTPN1FFAR1FFAR4 | |
| SCHEMBL9136460 | 1.00 | GPR84 (0.67) | GPR84SLC22A6PTPN1FFAR1FFAR4 | |
| SCHEMBL21552420 | 1.00 | GPR84 (0.67) | GPR84SLC22A6PTPN1FFAR1FFAR4 | |
| SCHEMBL6033635 | 1.00 | GPR84 (0.67) | GPR84SLC22A6PTPN1FFAR1FFAR4 | |
| SCHEMBL4748090 | 1.00 | GPR84 (0.67) | GPR84SLC22A6PTPN1FFAR1FFAR4 | |
| SCHEMBL18585612 | 1.00 | GPR84 (0.67) | GPR84SLC22A6PTPN1FFAR1FFAR4 | |
| SCHEMBL6033538 | 0.98 | GPR84 (0.63) | GPR84SLC22A6PTPN1FFAR1FFAR4 | |
| SCHEMBL3331926 | 0.91 | GPR84 (0.59) | GPR84SLC22A6PTPN1FFAR1FFAR4 | |
| SCHEMBL966415 | 0.88 | GPR84 (0.74) | GPR84SLC22A6FFAR1FFAR4GABRR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 129 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062720-A1 | Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof | AGAIN BIO APS (DK) | 2026-03-05 | — | — | US | claimed |
| US-20240309405-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | OXFORD FINANCE LLC | 2024-09-19 | — | — | US | claimed |
| US-11787900-B2 | Biodegradable sustainable polyesters | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-10-17 | — | — | US | claimed |
| US-20230151142-A1 | BIODEGRADABLE SUSTAINABLE POLYESTERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2023-05-18 | — | — | US | claimed |
| WO-2023081515-A1 | BIODEGRADABLE SUSTAINABLE POLYESTERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-05-11 | — | — | WO | claimed |
| US-20180243309-A1 | TOPICAL ANTIVIRAL COMPOSITIONS | TOPICAL REMEDY LLC (US) | 2018-08-30 | — | — | US | claimed |
| EP-3344265-A1 | TOPICAL ANTIVIRAL COMPOSITIONS | Topical Remedy, LLC (US) | 2018-07-11 | — | — | EP | claimed |
| US-9957533-B2 | Mutant of propionyl-CoA transferase from Clostridium propionicum and preparing method for PLA or PLA copolymer using the same | LG CHEM, LTD. (KR) | 2018-05-01 | — | — | US | claimed |
| US-9920338-B2 | Recombinant Ralstonia eutropha capable of producing polylactic acid or polylatic acid polymer, and method for producing polylactic acid or polylatic acid copolymer using same | LG CHEM, LTD. (KR) | 2018-03-20 | — | — | US | claimed |
| EP-2089522-B1 | MUTANTS OF PHA SYNTHASE FROM PSEUDOMONAS SP.6-19 AND METHOD FOR PREPARING LACTATE HOMOPOLYMER OR COPOLYMER USING THE SAME | LG CHEMICAL LTD (KR) | 2017-11-01 | — | — | EP | claimed |
| WO-2008113190-A1 | METHOD FOR THE PRODUCTION OF R-HYDROXYCARBOXYLIC ACIDS | EMPA EIDGENÖSSISCHE MATERIALPRÜFUNGS- UND FORSCHUNGSANSTALT (CH) | 2008-09-25 | — | — | WO | claimed |
| WO-2008062999-A1 | MUTANTS OF PHA SYNTHASE FROM PSEUDOMONAS SP.6-19 AND METHOD FOR PREPARING LACTATE HOMOPOLYMER OR COPOLYMER USING THE SAME | LG CHEM, LTD. (KR) | 2008-05-29 | — | — | WO | claimed |
| CN-101184843-A | Cell or plant having polylactic acid ester or copolymer thereof producing ability and method for producing polylactic acid ester or copolymer thereof | LG CHEMICAL LTD (KR) | 2008-05-21 | — | — | CN | claimed |
| EP-1885857-A1 | CELLS OR PLANTS HAVING A PRODUCING ABILITY OF POLYLACTATE OR ITS COPOLYMERS AND METHOD FOR PREPARING POLYLACTATE OR ITS COPOLYMERS USING THE SAME | LG Chem, Ltd. (KR) | 2008-02-13 | — | — | EP | claimed |
| US-20070277268-A1 | Cells or plants producing polylactate or its copolymers and uses thereof | LG CHEM, LTD. (KR) | 2007-11-29 | — | — | US | claimed |
| WO-2006126796-A1 | CELLS OR PLANTS HAVING A PRODUCING ABILITY OF POLYLACTATE OR ITS COPOLYMERS AND METHOD FOR PREPARING POLYLACTATE OR ITS COPOLYMERS USING THE SAME | LG CHEM, LTD. (KR) | 2006-11-30 | — | — | WO | claimed |
| EP-1036190-B1 | A METHOD FOR PRODUCING HYDROXYCARBOXYLIC ACIDS BY AUTO-DEGRADATION OF POLYHYDROXYALKANOATES | CHIROBIO INC (KR) | 2005-05-11 | — | — | EP | claimed |
| US-6472188-B1 | SYNTHESIZING AND ACCUMULATING POLYHYDROXYALKANOATES (PHA) IN A CELL OF A MICROORGANISM BY CULTURING THE MICROORGANISM HAVING POLYHYDROXYALKANOATE DEPOLYMERASE ACTIVITY, COLLECTING CULTURED POLYMER, SUBJECTING TO MICROBIAL ENZYME DEGRADATION | CHIROBIO INC. (KR) | 2002-10-29 | — | — | US | claimed |
| EP-1036190-A1 | A METHOD FOR PRODUCING HYDROXYCARBOXYLIC ACIDS BY AUTO-DEGRADATION OF POLYHYDROXYALKANOATES | ChiroBio Inc. (KR) | 2000-09-20 | — | — | EP | claimed |
| WO-1999029889-A1 | A METHOD FOR PRODUCING HYDROXYCARBOXYLIC ACIDS BY AUTO-DEGRADATION OF POLYHYDROXYALKANOATES | LG CHEMICAL LTD. (KR) | 1999-06-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062720-A1 | Multifunctional Fatty Acid Derivatives And Biosynthesis Thereof | FASN, FFAR1, FFAR3 | GPR84 924/4885SLC22A6 4754/4885PTPN1 1779/4885 |
| US-20240309405-A1 | MULTIFUNCTIONAL FATTY ACID DERIVATIVES AND BIOSYNTHESIS THEREOF | DGAT2, DGAT1, FASN | GPR84 1380/4885SLC22A6 4815/4885PTPN1 1903/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.